Hope for Parkinson’s disease symptoms is found in late-stage drug study
Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...
Outsourcing-pharma5d
AbbVie’s Parkinson’s disease monotherapy achieves positive phase 3 results
“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...
Medscape2d
Nonmotor Symptoms in Parkinson's Disease: The Dark Side of the Moon
Dopamine agonists may be useful in depression associated (or not) with PD and pramipexole has been demonstrated to have the same efficacy of selective serotonin-reuptake inhibitors (SSRIs).
AbbVie's Parkinson's disease drug improves patient mobility in late-stage study
AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...
Ozempic has a surprising side effect: Drinking less alcohol
People taking new weight-loss drugs say they curb cravings for booze, drugs, and nicotine. Did scientists inadvertently ...
PsyPost on MSN8d
Childhood maltreatment alters serotonin and dopamine receptor systems in primates, study finds
A study of rhesus macaques revealed that infants who experienced higher levels of maltreatment by their mothers tended to ...
The Financial Express6d
Cobenfy set to break dopamine dominance in schizophrenia treatment
According to GlobalData’s Drugs Database, the schizophrenia market remains dominated by dopamine-targeted mechanisms, such as ...